Analyst Christian Glennie from Stifel Nicolaus reiterated a Buy rating on Hikma Pharmaceuticals (HIK – Research Report) and keeping the ...
Needham analyst Michael Matson reiterated a Buy rating on Enovis (ENOV – Research Report) today and set a price target of $65.00. Michael ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback